Business Wire

Elstar Therapeutics Closes $39M Series A Financing to Support Development of its Universal Targeted Immunotherapy Platform

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elstar Therapeutics, a company fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapies, ...
Business Wire

eLstar Dynamics Develops New Smart Glass Array Design Achieving Superior Clarity with Minimal Optical Distortion

SAN JOSE, Calif.--(BUSINESS WIRE)--From Wireless Week 2022 – eLstar Dynamics, a leading developer of smart adaptive glass, announces the development of a new array design using an electrophoretic ...
DutchNews.NL

eLstar Dynamics Announces Ten Million Euros in Funding

Add as a favourite source on Google Add DutchNews as a favourite source on Google eLstar secures new funding to propel sustainable adaptive glass innovation, accelerate market launch, and drive down ...
DutchNews.NL

eLstar Dynamics and Morphotonics Collaborate to Achieve Flexible Spacer Design for Smart Glass Using Advanced Nanoimprinting Processes

Add as a favourite source on Google Add DutchNews as a favourite source on Google eLstar and Morphotonics successfully demonstrate new spacing capabilities as part of eLstar’s patented electrophoretic ...
Wall Street Journal

Funding Snapshot: Elstar Therapeutics Closes $39 Million Series A to Fight Cancer

Funding Snapshot: Elstar Therapeutics Closes $39 Million Series A to Fight Cancer WSJ Pro Jan. 3, 2018 12:15 pm ET ...
FierceBiotech

Big Pharma vets bag $39M to drive I-O firm Elstar forward

Elstar Therapeutics has raised $39 million. The series A positions a management team with résumés dotted with senior posts at Serono, Eli Lilly and Novartis to advance multifunctional anticancer drugs ...